SCHEMBL8320080

SCHEMBL8320080

O=C(NO)C1([S+]([O-])c2ccc3nc(N4CCC(Oc5ccc(OC(F)(F)F)cc5)CC4)sc3c2)CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.41
SCN4A P35499 1/20 0.41
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
MAPT P10636 3/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
MMP3 P08254 2/20 0.37
MMP9 P14780 2/20 0.37
MMP8 P22894 2/20 0.37
MMP1 P03956 1/20 0.37
MMP14 P50281 1/20 0.37
STAT3 P40763 1/20 0.37
HTT P42858 1/20 0.37
CASR P41180 1/20 0.37
NR1H4 Q96RI1 2/20 0.37
SCD O00767 1/20 0.36
TP53 P04637 1/20 0.36
TMPRSS15 P98073 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8321916 0.92 SCN4A (0.43) SCN9ASCN4ANPC1RAB9AMAPT
SCHEMBL8313399 0.89 SCN9A (0.37) SCN9ASCN4ANPC1RAB9AMAPT
SCHEMBL8321036 0.89 SCN9A (0.40) SCN9ASCN4ANPC1RAB9AMAPT
SCHEMBL6229769 0.83 MMP9 (0.55) MMP3MMP9MMP8MMP1MMP14
SCHEMBL6206247 0.78 SCN4A (0.43) SCN9ASCN4ANPC1RAB9AMAPT
SCHEMBL6701004 0.75 SCN9A (0.41) SCN9ASCN4ANPC1RAB9AMAPT
SCHEMBL8320969 0.74 MMP13 (0.56) MAPTMMP3MMP9MMP8MMP1
SCHEMBL8313312 0.72 RORC (0.39) NPC1RAB9ASMN1; SMN2MMP3MMP9
SCHEMBL8313531 0.70 MMP9 (0.49) MMP3MMP9MMP8MMP1MMP14
SCHEMBL8316327 0.70 MMP2 (0.36) NPC1RAB9AMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004048368-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS PHARMACIA CORPORATION (US) 2004-06-10 WO disclosed